                         SEQUENCE LISTING

<110>  H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
 
<120>  BETA-CATENIN AND B-CELL LYMPHOMA 9 (BCL9) INHIBITORS

<130>  10110-211WO1

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETIC CONSTRUCT

<400>  1

Gly Leu Ser Gln Glu Gln Leu Glu His Arg Glu Arg Ser Leu Gln Thr 
1               5                   10                  15      


Leu Arg Asp Ile Gln Arg Met Leu Phe Pro 
            20                  25      


<210>  2
<211>  54
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  SYNTHETIC CONSTRUCT

<400>  2

Ala Pro Pro Tyr Asp Ser Leu Leu Val Phe Asp Tyr Glu Gly Ser Gly 
1               5                   10                  15      


Ser Glu Ala Ala Ser Leu Ser Ser Leu Asn Ser Ser Glu Ser Asp Lys 
            20                  25                  30          


Asp Gln Asp Tyr Asp Tyr Leu Asn Glu Trp Gly Asn Arg Phe Lys Lys 
        35                  40                  45              


Leu Ala Asp Met Tyr Gly 
    50                  


